- Home
- DEI vs XENE Comparison
DEI vs XENE Comparison
Compare DEI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- XENE
- Stock Information
- Founded
- DEI 1971
- XENE 1996
- Country
- DEI United States
- XENE Canada
- Employees
- DEI N/A
- XENE N/A
- Industry
- DEI Real Estate Investment Trusts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- XENE Health Care
- Exchange
- DEI Nasdaq
- XENE Nasdaq
- Market Cap
- DEI 2.8B
- XENE 2.5B
- IPO Year
- DEI 2006
- XENE 2014
- Fundamental
- Price
- DEI $14.15
- XENE $38.20
- Analyst Decision
- DEI Buy
- XENE Strong Buy
- Analyst Count
- DEI 9
- XENE 8
- Target Price
- DEI $18.50
- XENE $56.38
- AVG Volume (30 Days)
- DEI 2.3M
- XENE 920.9K
- Earning Date
- DEI 05-06-2025
- XENE 05-08-2025
- Dividend Yield
- DEI 5.46%
- XENE N/A
- EPS Growth
- DEI N/A
- XENE N/A
- EPS
- DEI 0.13
- XENE N/A
- Revenue
- DEI $989,071,000.00
- XENE N/A
- Revenue This Year
- DEI $0.56
- XENE N/A
- Revenue Next Year
- DEI N/A
- XENE $1,553.36
- P/E Ratio
- DEI $105.02
- XENE N/A
- Revenue Growth
- DEI 0.46
- XENE N/A
- 52 Week Low
- DEI $12.39
- XENE $26.74
- 52 Week High
- DEI $20.50
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- DEI 44.35
- XENE 64.09
- Support Level
- DEI $13.38
- XENE $32.26
- Resistance Level
- DEI $14.56
- XENE $38.55
- Average True Range (ATR)
- DEI 0.81
- XENE 2.49
- MACD
- DEI 0.07
- XENE 0.94
- Stochastic Oscillator
- DEI 78.00
- XENE 97.04
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.